ConductScience.org, home

Paper28693199

Epidermal growth factor receptor in glioblastoma.

Xu H and 8 others. Oncol Lett, 2017. Cited by 123 papers, by iCite.

Cite this record

ConductScience Library. Epidermal growth factor receptor in glioblastoma. Papers, record 28693199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28693199

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Epidermal growth factor receptor in glioblastoma.
PubMed
Journal
Oncol Lett
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
4.77
iCite
Revised in PubMed
2024-01-09
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu HHongsheng
2Zong HHailiang
3Ma CChong
4Ming XXing
5Shang MMing
6Li KKai
7He XXiaoguang
8Du HHai
9Cao LLei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120124186Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.J Clin Oncol2010https://conductscience.org/library/papers/20124186PubMed
221775422Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.Mol Cancer Res2011https://conductscience.org/library/papers/21775422PubMed
319499221A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.Cancer Chemother Pharmacol2010https://conductscience.org/library/papers/19499221PubMed
412734385Epidermal growth factor receptor signaling intensity determines intracellular protein interactions, ubiquitination, and internalization.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12734385PubMed
514583498Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.Cancer Res2003https://conductscience.org/library/papers/14583498PubMed
67531822Protein modules and signalling networks.Nature1995https://conductscience.org/library/papers/7531822PubMed
719738203Oncogenic EGFR signaling networks in glioma.Sci Signal2009https://conductscience.org/library/papers/19738203PubMed
811302336Analysis of genomic rearrangements associated with EGRFvIII expression suggests involvement of Alu repeat elements.Neuro Oncol2000https://conductscience.org/library/papers/11302336PubMed
920150372A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy.Neuro Oncol2010https://conductscience.org/library/papers/20150372PubMed
1017177598Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.PLoS Med2006https://conductscience.org/library/papers/17177598PubMed
1117970081Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.Anticancer Res2007https://conductscience.org/library/papers/17970081PubMed
127518560Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor.Mol Cell Biol1994https://conductscience.org/library/papers/7518560PubMed
1320562912Lovastatin inhibits EGFR dimerization and AKT activation in squamous cell carcinoma cells: potential regulation by targeting rho proteins.Oncogene2010https://conductscience.org/library/papers/20562912PubMed
148695267Multiple infusions of anti-epidermal growth factor receptor (EGFR) monoclonal antibody (EMD 55,900) in patients with recurrent malignant gliomas.Eur J Cancer1996https://conductscience.org/library/papers/8695267PubMed
1524212795Glioma Specific Extracellular Missense Mutations in the First Cysteine Rich Region of Epidermal Growth Factor Receptor (EGFR) Initiate Ligand Independent Activation.Cancers (Basel)2011https://conductscience.org/library/papers/24212795PubMed
1616728632Targeting tyrosine kinases in cancer: the second wave.Science2006https://conductscience.org/library/papers/16728632PubMed
1715136790Development of novel targeted therapies in the treatment of malignant glioma.Nat Rev Drug Discov2004https://conductscience.org/library/papers/15136790PubMed
1819204207Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.J Clin Oncol2009https://conductscience.org/library/papers/19204207PubMed
1920085938The PI3K pathway as drug target in human cancer.J Clin Oncol2010https://conductscience.org/library/papers/20085938PubMed
208052651A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Proc Natl Acad Sci U S A1994https://conductscience.org/library/papers/8052651PubMed

See all 50 referencesDownload CSV of references

Cited by85

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
42694163Niemann-Pick type C1 protein regulates epidermal growth factor receptor stability in hepatic cells and facilitates the early steps of Hepatitis B virus infection.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42694163PubMed
42683315The ERK MAPK pathway in mesenchymal glioblastoma: tumorigenesis, microenvironmental reprogramming, and the therapeutic promise of RAS(ON) multi-selective inhibition.Front Mol Neurosci2026https://conductscience.org/library/papers/42683315PubMed
42589248Targeting Kinase Signaling in Glioblastoma: Structural Optimization, Blood-Brain Barrier Dynamics and Combinatorial Translational Strategies.Int J Mol Sci2026https://conductscience.org/library/papers/42589248PubMed
42566443A Transgenic mouse tolerant to syngeneic cancer cells expressing truncated human epidermal growth factor receptor.PLoS One2026https://conductscience.org/library/papers/42566443PubMed
42549406Targeting replication stress in glioblastoma: From genotoxic treatment and inhibitors of the DNA damage response to immunotherapy.Neurooncol Adv2026https://conductscience.org/library/papers/42549406PubMed
42279368Mitochondrial Metabolic Reprogramming in Colorectal Cancer-Associated Fibroblasts: An Up-to-Date Review.Cancers (Basel)2026https://conductscience.org/library/papers/42279368PubMed
42269611Small-molecule inhibitors of the protein kinase DYRK as potential therapeutic candidates in cancer.Cell Chem Biol2026https://conductscience.org/library/papers/42269611PubMed
41783089Tumor antigen only (TAO) vaccine platforms for glioblastoma therapeutics: a systematic review of evidence from clinical trials.EClinicalMedicine2026https://conductscience.org/library/papers/41783089PubMed
41497449Combined inhibition of lysine-specific demethylase 1 and kinase signaling as a preclinical treatment strategy in glioblastoma.Neurooncol Adv2025https://conductscience.org/library/papers/41497449PubMed
41493642An in silico approach to peptide-based dual-receptor targeting for IL13RA2 and VEGFR-2 extracellular domain.J Mol Model2026https://conductscience.org/library/papers/41493642PubMed
41473440A PET-CT study of the uptake of labeled aptamers [18F]FB-Gol1 and [18F]FB-GR20 in rat 101.8 glioblastoma model.Front Oncol2025https://conductscience.org/library/papers/41473440PubMed
41208963Emerging insights into the immunosuppressive tumor microenvironment and its implications for glioblastoma immunotherapy.Front Immunol2025https://conductscience.org/library/papers/41208963PubMed
41034696Characterisation of the expression of P2X7 receptor, cancer stem cell markers and immunological mediators in human high-grade gliomas.BMC Neurosci2025https://conductscience.org/library/papers/41034696PubMed
40781177Graphene quantum dot-integrated nanocomposites: a promising avenue for glioblastoma treatment.Med Oncol2025https://conductscience.org/library/papers/40781177PubMed
40722784Sex-Related Differences in Glioblastoma: A Single-Center Retrospective Cohort Study.Biomedicines2025https://conductscience.org/library/papers/40722784PubMed
40540177A New Insight in Cellular and Molecular Signaling Regulation for Neural Differentiation Program.Mol Neurobiol2025https://conductscience.org/library/papers/40540177PubMed
40241139Application of EGFR-TKIs in brain tumors, a breakthrough in future?J Transl Med2025https://conductscience.org/library/papers/40241139PubMed
39772250Human Melanoma and Glioblastoma Cells Express Cathepsins Supporting Reovirus Moscow Strain Infection.Viruses2024https://conductscience.org/library/papers/39772250PubMed
39607670Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma.Pharmacol Rep2025https://conductscience.org/library/papers/39607670PubMed
39518074Evolution of Molecular Biomarkers and Precision Molecular Therapeutic Strategies in Glioblastoma.Cancers (Basel)2024https://conductscience.org/library/papers/39518074PubMed

See all 85 cited byDownload CSV of cited by

Genes21

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERBB32065PubTator's text mininghttps://conductscience.org/library/genes/2065NCBI Gene
ERBB42066PubTator's text mininghttps://conductscience.org/library/genes/2066NCBI Gene
ERVK-15100616443PubTator's text mininghttps://conductscience.org/library/genes/100616443NCBI Gene
FYN2534PubTator's text mininghttps://conductscience.org/library/genes/2534NCBI Gene
GRB22885PubTator's text mininghttps://conductscience.org/library/genes/2885NCBI Gene
PIK3CA5290PubTator's text mininghttps://conductscience.org/library/genes/5290NCBI Gene
PIK3R15295PubTator's text mininghttps://conductscience.org/library/genes/5295NCBI Gene
PIK3R25296PubTator's text mininghttps://conductscience.org/library/genes/5296NCBI Gene
PROM18842PubTator's text mininghttps://conductscience.org/library/genes/8842NCBI Gene
PRRT2112476PubTator's text mininghttps://conductscience.org/library/genes/112476NCBI Gene
PTEN5728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
SHC16464PubTator's text mininghttps://conductscience.org/library/genes/6464NCBI Gene
SOS16654PubTator's text mininghttps://conductscience.org/library/genes/6654NCBI Gene
SRC6714PubTator's text mininghttps://conductscience.org/library/genes/6714NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene

See all 21 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28693199

GET https://conductscience.org/api/papers/v1/28693199/references?page=2